首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >Clinicopathological features of patients with middle third gastric carcinoma
【2h】

Clinicopathological features of patients with middle third gastric carcinoma

机译:中度第三胃癌患者的临床病理特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To compared the prognosis of middle third gastric carcinoma (MGC) patients with those of patients with proximal/distal gastric carcinoma (PGC/DGC).METHODS: Of 3299 patients diagnosed with gastric carcinoma who underwent surgery at our hospital over a 15-year period, 919 (27.9%) were diagnosed with MGC. For each patient, the following information was obtained from hospital records: Age, sex, tumor size, depth of invasion, histologic type, nodal involvement, extent of lymph node dissection, hepatic metastasis, peritoneal dissemination, stage at initial diagnosis, operative type, curability, and survival rate.RESULTS: T1 category tumors were more common in patients with MGC than in patients with PGC (P < 0.001). Tumor stage (stage I), N category (N0), and T category (T1) significantly influenced the 5-year survival rates for patients with curatively resected tumors. A multivariate analysis showed that age, tumor size, serosal invasion, lymph node metastasis, and curability were significant predictors of survival in patients with MGC. The survival rate for MGC patients was similar to that for PGC/DGC patients (52.8% vs 44.4%/51.4%, P = 0.1138). The 5-year survival rate for MGC patients with curative resection was higher than that for MGC patients with non-curative resection (62.9% vs 8.7%, P < 0.001).CONCLUSION: These results indicate that tumor location did not affect the prognosis. Curative resection is important for improving the prognosis of patients with MGC.
机译:目的:比较中三期胃癌(MGC)患者与近端/远端胃癌(PGC / DGC)患者的预后。方法:在我院接受手术治疗且超过15-去年同期,有919名(27.9%)被诊断患有MGC。对于每位患者,从医院记录中获得以下信息:年龄,性别,肿瘤大小,浸润深度,组织学类型,淋巴结受累,淋巴结清扫范围,肝转移,腹膜播散,初步诊断阶段,手术类型,结果:T1类肿瘤在MGC患者中比在PGC患者中更为常见(P <0.001)。肿瘤分期(I期),N类(N0)和T类(T1)显着影响治愈性切除肿瘤患者的5年生存率。多因素分析表明,年龄,肿瘤大小,浆膜浸润,淋巴结转移和可治愈性是MGC患者生存的重要预测指标。 MGC患者的生存率与PGC / DGC患者的生存率相似(52.8%对44.4%/ 51.4%,P = 0.1138)。结论:MGC根治性切除术的5年生存率高于非根治性切除术的MGC患者(62.9%vs. 8.7%,P <0.001)。结论:这些结果表明肿瘤的位置并不影响预后。根治性切除对于改善MGC患者的预后非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号